Kevin Lavelle is a partner in Robbins Geller Rudman & Dowd LLP’s San Diego office, where his practice focuses on complex securities litigation.
Lawdragon Honors
| Honor | Year | Practice |
|---|---|---|
| The 2025 Lawdragon 500 X – The Next Generation | 2025 | Plaintiff Securities Litigation |
| The 2024 Lawdragon 500 X – The Next Generation | 2024 | Plaintiff Securities Litigation |
| Lawdragon 500 X – The Next Generation | 2023 | Plaintiff Securities Litigation |
Lavelle has served on numerous litigation teams and helped obtain over $500 million for investors. His work includes several significant recoveries against corporations, including HCA Holdings, Inc. ($215 million); Altria Group and JUUL Labs ($90 million); Endo Pharmaceuticals ($63 million); and Intercept Pharmaceuticals ($55 million), among others.
Lavelle has been included in the 500 X - The Next Generation Lawdragon guide. Kevin graduated with honors from Brooklyn Law School, where he was a recipient of the Prince and Dean’s Merit Scholarships. Prior to law school, he earned a Bachelor of Arts degree with honors from the College of the Holy Cross.
Lavelle worked as a summer associate for the Firm and joined Robbins Geller upon graduation from law school.